(ANSA) - LONDON, MARCH 18 - The British drug agency (Mhra) formally excludes that there is any evidence of a link between the use of AstraZeneca's anti-Covid vaccine and individual cases of blood clots diagnosed in some people after administration, and therefore recommends continuing to inoculate this serum: never discontinued in the UK and already received by millions of individuals.
Sky reports this, anticipating the press conference in Downing Street in which MHRA number one, Dr. June Raine, will participate in the afternoon alongside Prime Minister Boris Johnson.
(HANDLE).